Kun Xie Selected Research

Kun Xie Research Topics

Disease

27	Neoplasms (Cancer) 09/2023 - 11/2010
7	Inflammation (Inflammations) 01/2024 - 10/2017
5	Carcinoma (Carcinomatosis) 01/2022 - 11/2013
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 07/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019 - 05/2012
3	Cholangiocarcinoma 12/2022 - 01/2015
3	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2012
3	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 12/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
2	Infections 01/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2019
2	Atrial Fibrillation 11/2020 - 09/2019
2	Ischemic Stroke 11/2020 - 09/2019
2	Reperfusion Injury 01/2020 - 12/2019
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 12/2019
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2016 - 04/2012
1	Psychotic Disorders (Schizoaffective Disorder) 02/2024
1	Coccidiosis 01/2024
1	Carcinogenesis 09/2023
1	Keloid 01/2023
1	Aflatoxin Poisoning 03/2022
1	Myocardial Infarction 02/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Fournier Gangrene 01/2022
1	Coinfection 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Diarrhea 01/2022
1	Colonic Neoplasms (Colon Cancer) 12/2021
1	Osteoporotic Fractures 06/2021
1	Hyperemia 03/2021
1	Renal Insufficiency (Renal Failure) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Cognitive Dysfunction 01/2021
1	Heart Failure 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Atherosclerosis 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Stroke (Strokes) 11/2020
1	Thrombosis (Thrombus) 11/2020
1	Non-alcoholic Fatty Liver Disease 07/2020

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2015
4	Small Interfering RNA (siRNA)IBA 02/2016 - 05/2012
3	AntibodiesIBA 12/2022 - 06/2017
3	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2010
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 05/2019
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2024 - 09/2022
2	NucleotidesIBA 09/2023 - 01/2020
2	pembrolizumabIBA 12/2022 - 01/2020
2	CytokinesIBA 03/2022 - 10/2020
2	Messenger RNA (mRNA)IBA 03/2022 - 12/2019
2	Caspase 3 (Caspase-3)IBA 03/2022 - 12/2019
2	RNA (Ribonucleic Acid)IBA 12/2021 - 04/2014
2	oxidized low density lipoproteinIBA 01/2021 - 11/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2019
2	Antineoplastic Agents (Antineoplastics)IBA 10/2020 - 11/2010
2	Dexmedetomidine FDA Link 01/2020 - 12/2019
2	Triglycerides (Triacylglycerol)IBA 12/2019 - 05/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 04/2014
1	Secretory Immunoglobulin A (SIgA)IBA 01/2024
1	AntioxidantsIBA 01/2024
1	Complex MixturesIBA 07/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2022
1	CateninsIBA 12/2022
1	AlkaloidsIBA 09/2022
1	astaxanthine (astaxanthin)IBA 09/2022
1	fucoidanIBA 09/2022
1	OccludinIBA 03/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2022
1	Cilostazol (Pletal)FDA LinkGeneric 02/2022
1	disitamab vedotinIBA 01/2022
1	Indoleacetic Acids (Auxin)IBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	VaccinesIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 12/2021
1	B7-H1 AntigenIBA 12/2021
1	Vitamin D FDA LinkGeneric 06/2021
1	Proline (L-Proline)FDA Link 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	SodiumIBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	LDL CholesterolIBA 11/2020
1	Interleukin-12 (IL 12)IBA 10/2020
1	dihydromyricetinIBA 07/2020
1	TeaIBA 07/2020

Therapy/Procedure

12	Therapeutics 01/2022 - 11/2010
4	Hepatectomy 12/2021 - 09/2014
3	Perforator Flap 01/2023 - 11/2014
3	Radiotherapy 01/2023 - 02/2016
3	Immunotherapy 01/2021 - 06/2017
2	Negative-Pressure Wound Therapy 01/2022 - 03/2021
2	Drug Therapy (Chemotherapy) 11/2013 - 11/2010
2	Length of Stay 07/2012 - 04/2012
1	Transplantation 01/2023
1	Nephrectomy 06/2022
1	Oral Administration 01/2022
1	Neoadjuvant Therapy 01/2021